Education
About Us
Working with TipRanks
Follow Us
RUA Life Sciences (GB:RUA)
LSE:RUA
RUA Stock Chart & Stats
Day’s Range― - ―
52-Week Range10.33p - 15.70p
Previous CloseN/A
Volume378.53K
Average Volume (3M)120.42K
Market Cap
£6.98M
Enterprise Value5.00M
Total Cash (Recent Filing)£3.78M
Total Debt (Recent Filing)£1.18M
Price to Earnings (P/E)1125.0
Beta0.28
Next Earnings
Dec 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding62,060,272
10 Day Avg. Volume219,993
30 Day Avg. Volume120,417
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RUA Life Sciences News
RUA FAQ
What was RUA Life Sciences’s price range in the past 12 months?
RUA Life Sciences lowest share price was 10.33p and its highest was 15.70p in the past 12 months.
What is RUA Life Sciences’s market cap?
RUA Life Sciences’s market cap is £6.98M.
When is RUA Life Sciences’s upcoming earnings report date?
RUA Life Sciences’s upcoming earnings report date is Dec 11, 2025 which is in 86 days.
How were RUA Life Sciences’s earnings last quarter?
RUA Life Sciences released its earnings results on Jun 25, 2025. The company reported -0.01p earnings per share for the quarter, missing the consensus estimate of N/A by -0.01p.
Is RUA Life Sciences overvalued?
According to Wall Street analysts RUA Life Sciences’s price is currently Overvalued.
Does RUA Life Sciences pay dividends?
RUA Life Sciences does not currently pay dividends.
What is RUA Life Sciences’s EPS estimate?
RUA Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RUA Life Sciences have?
RUA Life Sciences has 62,060,272 shares outstanding.
What happened to RUA Life Sciences’s price movement after its last earnings report?
RUA Life Sciences reported an EPS of -0.01p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.982%.
Which hedge fund is a major shareholder of RUA Life Sciences?
Currently, no hedge funds are holding shares in GB:RUA
Company Description
RUA Life Sciences
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.
Technical Analysis
MyHealthChecked PLC
―
Inspiration Healthcare
―
Oxford BioDynamics
―
HemoGenyx Pharmaceuticals Plc
―
Surgical Innovations
―
Options Prices
Currently, No data available
---